Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Duke University says it’s “an enormous setback” for creating a vaccine to fight the cause of AIDS. The Trump administration ...

The current presidential administration has ended funding for the Center for HIV/AIDS Vaccine Development (CHAVD), a move ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

HHS did not answer written questions about Monarez’s nomination, her current role at the CDC or her salary. An employee ...

Childhood vaccination rates have markedly declined across the U.S. since the start of COVID, according to new Johns Hopkins ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

To access our most recent research and articles on Covid-19 ... and communities to administer them widely. The NEJM Vaccine Resource Center helps busy clinicians with practical information and ...

The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, work that was led in part by Duke Health. "Without funding, the major thing ...

Stephanie Lathrop, a senior scientist in the Center for Translational Medicine ... Newcomer said despite the efforts to shut down vaccine research, she will continue promoting access to immunizati ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...